ClinicalTrials.Veeva

Menu

Dysfunctional Hemoglobin

N

Nonin Medical

Status

Completed

Conditions

Elevated Levels of Carboxyhemoglobin and Methemoglobin

Treatments

Other: Elevated levels of carboxyhemoglobin

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02262195
QATP2338

Details and patient eligibility

About

The purpose of the study is to determine if a new pulse oximeter accurately detects carboxyhemoglobin and methemoglobin when intentionally increased in the blood.

Enrollment

62 patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subjects does not have significant medical problems
  • Subject is willing to provide written informed consent
  • Subject is between 18 and 45 years of age

Exclusion criteria

  • Has a BMI greater than 31
  • Has had any relevant injury at the sensor location site
  • Has deformities or abnormalities that may prevent proper application of the device under test
  • Has a known respiratory condition
  • Is currently a smoker
  • Has a known heart or cardiovascular condition
  • Is currently pregnant
  • Is female and actively trying to get pregnant
  • Has a clotting disorder
  • Is known to have a hemoglobinopathy such as (anemia, bilirubinemia, sickle-cell anemia, inherited or congenital methemoglobinemia)
  • The subject has a COHb greater than 3% or MetHb greater than 2%
  • Has taken blood thinners or medication with aspirin within the last 24 hours
  • Has unacceptable collateral circulation from the ulnar artery
  • Has donated more than 300 mL of blood within one month prior to start of study
  • Is unwilling or unable to provide written informed consent to participate in the study
  • Is unwilling or unable to comply with the study procedures
  • Has another health condition which in the opinion of the principal investigator makes him/her unsuitable for testing

Trial design

62 participants in 2 patient groups

Carboxyhemoglobin
Description:
Induced carboxyhemoglobin levels up tp 15 percent.
Treatment:
Other: Elevated levels of carboxyhemoglobin
Methemoglobin
Description:
Induced methemoglobin levels up to 15 percent.
Treatment:
Other: Elevated levels of carboxyhemoglobin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems